nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.213	0.506	CrCtD
Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.208	0.494	CrCtD
Fludrocortisone—NR3C2—Prednisolone—chronic obstructive pulmonary disease	0.123	0.609	CbGbCtD
Fludrocortisone—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0407	0.201	CbGbCtD
Fludrocortisone—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0384	0.19	CbGbCtD
Fludrocortisone—Potassium Canrenoate—Prednisone—chronic obstructive pulmonary disease	0.011	0.038	CrCrCtD
Fludrocortisone—Potassium Canrenoate—Prednisolone—chronic obstructive pulmonary disease	0.0107	0.0371	CrCrCtD
Fludrocortisone—Flurandrenolide—Prednisolone—chronic obstructive pulmonary disease	0.0084	0.0291	CrCrCtD
Fludrocortisone—Hydrocortamate—Prednisone—chronic obstructive pulmonary disease	0.00805	0.0279	CrCrCtD
Fludrocortisone—Hydrocortamate—Prednisolone—chronic obstructive pulmonary disease	0.00786	0.0272	CrCrCtD
Fludrocortisone—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.00781	0.027	CrCrCtD
Fludrocortisone—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.00762	0.0264	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00698	0.0242	CrCrCtD
Fludrocortisone—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.00696	0.0241	CrCrCtD
Fludrocortisone—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.00679	0.0235	CrCrCtD
Fludrocortisone—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.00679	0.0235	CrCrCtD
Fludrocortisone—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00678	0.0235	CrCrCtD
Fludrocortisone—Desonide—Prednisone—chronic obstructive pulmonary disease	0.00678	0.0235	CrCrCtD
Fludrocortisone—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00678	0.0235	CrCrCtD
Fludrocortisone—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.00662	0.0229	CrCrCtD
Fludrocortisone—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.00662	0.0229	CrCrCtD
Fludrocortisone—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00662	0.0229	CrCrCtD
Fludrocortisone—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.00662	0.0229	CrCrCtD
Fludrocortisone—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00662	0.0229	CrCrCtD
Fludrocortisone—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.00661	0.0229	CrCrCtD
Fludrocortisone—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.00645	0.0223	CrCrCtD
Fludrocortisone—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00645	0.0223	CrCrCtD
Fludrocortisone—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.0063	0.0218	CrCrCtD
Fludrocortisone—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.0063	0.0218	CrCrCtD
Fludrocortisone—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.0063	0.0218	CrCrCtD
Fludrocortisone—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.0063	0.0218	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.0063	0.0218	CrCrCtD
Fludrocortisone—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.0063	0.0218	CrCrCtD
Fludrocortisone—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00615	0.0213	CrCrCtD
Fludrocortisone—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00615	0.0213	CrCrCtD
Fludrocortisone—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00615	0.0213	CrCrCtD
Fludrocortisone—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.00615	0.0213	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00615	0.0213	CrCrCtD
Fludrocortisone—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.00615	0.0213	CrCrCtD
Fludrocortisone—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00615	0.0213	CrCrCtD
Fludrocortisone—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00601	0.0208	CrCrCtD
Fludrocortisone—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00601	0.0208	CrCrCtD
Fludrocortisone—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.00589	0.0204	CrCrCtD
Fludrocortisone—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00576	0.02	CrCrCtD
Fludrocortisone—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.00575	0.0199	CrCrCtD
Fludrocortisone—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.00575	0.0199	CrCrCtD
Fludrocortisone—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00553	0.0192	CrCrCtD
Fludrocortisone—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0054	0.0187	CrCrCtD
Fludrocortisone—Fat atrophy—Prednisone—chronic obstructive pulmonary disease	0.0037	0.0465	CcSEcCtD
Fludrocortisone—Alkalosis hypokalaemic—Prednisolone—chronic obstructive pulmonary disease	0.00187	0.0235	CcSEcCtD
Fludrocortisone—Increased insulin requirement—Prednisolone—chronic obstructive pulmonary disease	0.00168	0.0211	CcSEcCtD
Fludrocortisone—Oesophagitis ulcerative—Prednisolone—chronic obstructive pulmonary disease	0.00168	0.0211	CcSEcCtD
Fludrocortisone—Glucose tolerance decreased—Formoterol—chronic obstructive pulmonary disease	0.00162	0.0204	CcSEcCtD
Fludrocortisone—Glucose tolerance decreased—Arformoterol—chronic obstructive pulmonary disease	0.00162	0.0204	CcSEcCtD
Fludrocortisone—Aseptic necrosis—Prednisolone—chronic obstructive pulmonary disease	0.00153	0.0192	CcSEcCtD
Fludrocortisone—Steroid myopathy—Prednisolone—chronic obstructive pulmonary disease	0.00153	0.0192	CcSEcCtD
Fludrocortisone—Spinal compression fracture—Prednisolone—chronic obstructive pulmonary disease	0.0014	0.0177	CcSEcCtD
Fludrocortisone—Nitrogen balance negative—Prednisolone—chronic obstructive pulmonary disease	0.0014	0.0177	CcSEcCtD
Fludrocortisone—Carbohydrate tolerance decreased—Prednisolone—chronic obstructive pulmonary disease	0.0014	0.0177	CcSEcCtD
Fludrocortisone—Muscle mass—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.0164	CcSEcCtD
Fludrocortisone—Lipoatrophy—Prednisone—chronic obstructive pulmonary disease	0.00122	0.0154	CcSEcCtD
Fludrocortisone—Oesophagitis ulcerative—Prednisone—chronic obstructive pulmonary disease	0.00122	0.0154	CcSEcCtD
Fludrocortisone—Increased insulin requirement—Prednisone—chronic obstructive pulmonary disease	0.00122	0.0154	CcSEcCtD
Fludrocortisone—Aseptic necrosis—Prednisone—chronic obstructive pulmonary disease	0.00111	0.014	CcSEcCtD
Fludrocortisone—Steroid myopathy—Prednisone—chronic obstructive pulmonary disease	0.00111	0.014	CcSEcCtD
Fludrocortisone—Carbohydrate tolerance decreased—Prednisone—chronic obstructive pulmonary disease	0.00102	0.0128	CcSEcCtD
Fludrocortisone—Nitrogen balance negative—Prednisone—chronic obstructive pulmonary disease	0.00102	0.0128	CcSEcCtD
Fludrocortisone—Spinal compression fracture—Prednisone—chronic obstructive pulmonary disease	0.00102	0.0128	CcSEcCtD
Fludrocortisone—Erythema facial—Prednisolone—chronic obstructive pulmonary disease	0.000964	0.0121	CcSEcCtD
Fludrocortisone—Muscle mass—Prednisone—chronic obstructive pulmonary disease	0.000945	0.0119	CcSEcCtD
Fludrocortisone—Exophthalmos—Prednisolone—chronic obstructive pulmonary disease	0.000918	0.0116	CcSEcCtD
Fludrocortisone—Intraocular pressure increased—Tiotropium—chronic obstructive pulmonary disease	0.000916	0.0115	CcSEcCtD
Fludrocortisone—Erythema facial—Prednisone—chronic obstructive pulmonary disease	0.0007	0.00882	CcSEcCtD
Fludrocortisone—Angiitis necrotising—Prednisone—chronic obstructive pulmonary disease	0.0007	0.00882	CcSEcCtD
Fludrocortisone—Trauma—Arformoterol—chronic obstructive pulmonary disease	0.000683	0.00859	CcSEcCtD
Fludrocortisone—Trauma—Formoterol—chronic obstructive pulmonary disease	0.000683	0.00859	CcSEcCtD
Fludrocortisone—Cataract subcapsular—Prednisolone—chronic obstructive pulmonary disease	0.000674	0.00849	CcSEcCtD
Fludrocortisone—Trauma—Montelukast—chronic obstructive pulmonary disease	0.000669	0.00842	CcSEcCtD
Fludrocortisone—Exophthalmos—Prednisone—chronic obstructive pulmonary disease	0.000667	0.0084	CcSEcCtD
Fludrocortisone—Glucose tolerance impaired—Prednisolone—chronic obstructive pulmonary disease	0.000654	0.00823	CcSEcCtD
Fludrocortisone—Peptic ulcer—Aminophylline—chronic obstructive pulmonary disease	0.000639	0.00804	CcSEcCtD
Fludrocortisone—Glucose tolerance decreased—Prednisone—chronic obstructive pulmonary disease	0.000637	0.00802	CcSEcCtD
Fludrocortisone—Vasculitis necrotising—Prednisone—chronic obstructive pulmonary disease	0.00061	0.00768	CcSEcCtD
Fludrocortisone—Benign intracranial hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000599	0.00754	CcSEcCtD
Fludrocortisone—Papilloedema—Prednisolone—chronic obstructive pulmonary disease	0.000554	0.00697	CcSEcCtD
Fludrocortisone—Skin striae—Prednisolone—chronic obstructive pulmonary disease	0.000554	0.00697	CcSEcCtD
Fludrocortisone—Muscle atrophy—Prednisone—chronic obstructive pulmonary disease	0.000543	0.00683	CcSEcCtD
Fludrocortisone—Atrophy—Prednisolone—chronic obstructive pulmonary disease	0.00054	0.0068	CcSEcCtD
Fludrocortisone—Glaucoma—Tiotropium—chronic obstructive pulmonary disease	0.000535	0.00673	CcSEcCtD
Fludrocortisone—Acneiform eruption—Prednisone—chronic obstructive pulmonary disease	0.000506	0.00637	CcSEcCtD
Fludrocortisone—Cataract subcapsular—Prednisone—chronic obstructive pulmonary disease	0.00049	0.00617	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—ACE—chronic obstructive pulmonary disease	0.000489	0.134	CbGpPWpGaD
Fludrocortisone—Cardiomegaly—Prednisolone—chronic obstructive pulmonary disease	0.000482	0.00607	CcSEcCtD
Fludrocortisone—Glucose tolerance impaired—Prednisone—chronic obstructive pulmonary disease	0.000475	0.00598	CcSEcCtD
Fludrocortisone—Osteonecrosis—Prednisolone—chronic obstructive pulmonary disease	0.000473	0.00595	CcSEcCtD
Fludrocortisone—NR3C2—connective tissue—chronic obstructive pulmonary disease	0.000438	0.102	CbGeAlD
Fludrocortisone—Benign intracranial hypertension—Prednisone—chronic obstructive pulmonary disease	0.000435	0.00548	CcSEcCtD
Fludrocortisone—Glaucoma—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00543	CcSEcCtD
Fludrocortisone—Glaucoma—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00543	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00542	CcSEcCtD
Fludrocortisone—Cataract—Tiotropium—chronic obstructive pulmonary disease	0.000423	0.00533	CcSEcCtD
Fludrocortisone—Intracranial pressure increased—Prednisolone—chronic obstructive pulmonary disease	0.000421	0.00531	CcSEcCtD
Fludrocortisone—NR3C2—bronchus—chronic obstructive pulmonary disease	0.00041	0.0958	CbGeAlD
Fludrocortisone—Impaired healing—Prednisolone—chronic obstructive pulmonary disease	0.000407	0.00512	CcSEcCtD
Fludrocortisone—Skin striae—Prednisone—chronic obstructive pulmonary disease	0.000402	0.00506	CcSEcCtD
Fludrocortisone—Papilloedema—Prednisone—chronic obstructive pulmonary disease	0.000402	0.00506	CcSEcCtD
Fludrocortisone—Glycosuria—Arformoterol—chronic obstructive pulmonary disease	0.000401	0.00505	CcSEcCtD
Fludrocortisone—Glycosuria—Formoterol—chronic obstructive pulmonary disease	0.000401	0.00505	CcSEcCtD
Fludrocortisone—NR3C2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000401	0.0937	CbGeAlD
Fludrocortisone—Intraocular pressure increased—Prednisolone—chronic obstructive pulmonary disease	0.0004	0.00504	CcSEcCtD
Fludrocortisone—Atrophy—Prednisone—chronic obstructive pulmonary disease	0.000392	0.00494	CcSEcCtD
Fludrocortisone—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.00477	CcSEcCtD
Fludrocortisone—Dermatitis acneiform—Prednisone—chronic obstructive pulmonary disease	0.000374	0.00471	CcSEcCtD
Fludrocortisone—Trauma—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00465	CcSEcCtD
Fludrocortisone—NR3C2—trachea—chronic obstructive pulmonary disease	0.000368	0.086	CbGeAlD
Fludrocortisone—Contusion—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00459	CcSEcCtD
Fludrocortisone—Cardiomegaly—Prednisone—chronic obstructive pulmonary disease	0.000351	0.00441	CcSEcCtD
Fludrocortisone—Osteonecrosis—Prednisone—chronic obstructive pulmonary disease	0.000343	0.00432	CcSEcCtD
Fludrocortisone—Hypernatraemia—Prednisolone—chronic obstructive pulmonary disease	0.000335	0.00421	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—SCGB1A1—chronic obstructive pulmonary disease	0.000332	0.0907	CbGpPWpGaD
Fludrocortisone—AR—connective tissue—chronic obstructive pulmonary disease	0.000325	0.0759	CbGeAlD
Fludrocortisone—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.00032	0.00403	CcSEcCtD
Fludrocortisone—Menstruation irregular—Prednisolone—chronic obstructive pulmonary disease	0.000318	0.004	CcSEcCtD
Fludrocortisone—Osteoporosis—Prednisolone—chronic obstructive pulmonary disease	0.000314	0.00395	CcSEcCtD
Fludrocortisone—Intracranial pressure increased—Prednisone—chronic obstructive pulmonary disease	0.000306	0.00386	CcSEcCtD
Fludrocortisone—AR—bronchus—chronic obstructive pulmonary disease	0.000303	0.0709	CbGeAlD
Fludrocortisone—Hirsutism—Prednisolone—chronic obstructive pulmonary disease	0.000303	0.00381	CcSEcCtD
Fludrocortisone—AR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000297	0.0694	CbGeAlD
Fludrocortisone—Impaired healing—Prednisone—chronic obstructive pulmonary disease	0.000296	0.00372	CcSEcCtD
Fludrocortisone—Neoplasm—Formoterol—chronic obstructive pulmonary disease	0.000294	0.0037	CcSEcCtD
Fludrocortisone—Neoplasm—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.0037	CcSEcCtD
Fludrocortisone—Intraocular pressure increased—Prednisone—chronic obstructive pulmonary disease	0.000291	0.00366	CcSEcCtD
Fludrocortisone—Optic neuritis—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.0036	CcSEcCtD
Fludrocortisone—Trauma—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00338	CcSEcCtD
Fludrocortisone—NR3C1—respiratory system—chronic obstructive pulmonary disease	0.000267	0.0624	CbGeAlD
Fludrocortisone—NR3C2—lung—chronic obstructive pulmonary disease	0.000264	0.0618	CbGeAlD
Fludrocortisone—Peptic ulcer—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.00332	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00328	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00328	CcSEcCtD
Fludrocortisone—Injury—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00323	CcSEcCtD
Fludrocortisone—Injury—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00323	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00322	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.000252	0.0687	CbGpPWpGaD
Fludrocortisone—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000252	0.00317	CcSEcCtD
Fludrocortisone—Injury—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00317	CcSEcCtD
Fludrocortisone—Myopathy—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.00316	CcSEcCtD
Fludrocortisone—Hypernatraemia—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00306	CcSEcCtD
Fludrocortisone—Injury—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00305	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00304	CcSEcCtD
Fludrocortisone—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000238	0.003	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.00299	CcSEcCtD
Fludrocortisone—NR3C1—connective tissue—chronic obstructive pulmonary disease	0.000235	0.055	CbGeAlD
Fludrocortisone—Glaucoma—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00294	CcSEcCtD
Fludrocortisone—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.000231	0.00291	CcSEcCtD
Fludrocortisone—Osteoporosis—Prednisone—chronic obstructive pulmonary disease	0.000228	0.00287	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00287	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—NOS3—chronic obstructive pulmonary disease	0.000228	0.0622	CbGpPWpGaD
Fludrocortisone—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000227	0.00286	CcSEcCtD
Fludrocortisone—Multiple fractures—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00277	CcSEcCtD
Fludrocortisone—Hirsutism—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00277	CcSEcCtD
Fludrocortisone—Fracture—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00277	CcSEcCtD
Fludrocortisone—NR3C1—bronchus—chronic obstructive pulmonary disease	0.00022	0.0514	CbGeAlD
Fludrocortisone—Affect lability—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00276	CcSEcCtD
Fludrocortisone—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000215	0.0503	CbGeAlD
Fludrocortisone—Petechiae—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.00269	CcSEcCtD
Fludrocortisone—Mood swings—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00266	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000208	0.00262	CcSEcCtD
Fludrocortisone—Optic neuritis—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00262	CcSEcCtD
Fludrocortisone—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000207	0.0026	CcSEcCtD
Fludrocortisone—NR3C1—trachea—chronic obstructive pulmonary disease	0.000197	0.0461	CbGeAlD
Fludrocortisone—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00247	CcSEcCtD
Fludrocortisone—AR—lung—chronic obstructive pulmonary disease	0.000196	0.0458	CbGeAlD
Fludrocortisone—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00244	CcSEcCtD
Fludrocortisone—Peptic ulcer—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00241	CcSEcCtD
Fludrocortisone—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00236	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00232	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00232	CcSEcCtD
Fludrocortisone—Myopathy—Prednisone—chronic obstructive pulmonary disease	0.000182	0.0023	CcSEcCtD
Fludrocortisone—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000182	0.00229	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00219	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00218	CcSEcCtD
Fludrocortisone—Glaucoma—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00214	CcSEcCtD
Fludrocortisone—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000168	0.00212	CcSEcCtD
Fludrocortisone—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.0021	CcSEcCtD
Fludrocortisone—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000164	0.00206	CcSEcCtD
Fludrocortisone—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.00204	CcSEcCtD
Fludrocortisone—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.002	CcSEcCtD
Fludrocortisone—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00199	CcSEcCtD
Fludrocortisone—Petechiae—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00196	CcSEcCtD
Fludrocortisone—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00195	CcSEcCtD
Fludrocortisone—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00194	CcSEcCtD
Fludrocortisone—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.188	CrCbGaD
Fludrocortisone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000152	0.00192	CcSEcCtD
Fludrocortisone—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.00191	CcSEcCtD
Fludrocortisone—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00191	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000151	0.0411	CbGpPWpGaD
Fludrocortisone—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00015	0.00189	CcSEcCtD
Fludrocortisone—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	0.000148	0.181	CrCbGaD
Fludrocortisone—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00186	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00185	CcSEcCtD
Fludrocortisone—Contusion—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00185	CcSEcCtD
Fludrocortisone—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00183	CcSEcCtD
Fludrocortisone—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.00181	CcSEcCtD
Fludrocortisone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000143	0.0018	CcSEcCtD
Fludrocortisone—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000143	0.0018	CcSEcCtD
Fludrocortisone—NR3C1—lung—chronic obstructive pulmonary disease	0.000142	0.0332	CbGeAlD
Fludrocortisone—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00177	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00014	0.0383	CbGpPWpGaD
Fludrocortisone—Injury—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00175	CcSEcCtD
Fludrocortisone—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000138	0.00173	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.000136	0.0371	CbGpPWpGaD
Fludrocortisone—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00169	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00166	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000131	0.00165	CcSEcCtD
Fludrocortisone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00013	0.00164	CcSEcCtD
Fludrocortisone—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00158	CcSEcCtD
Fludrocortisone—Dexamethasone—NOS2—chronic obstructive pulmonary disease	0.000125	0.153	CrCbGaD
Fludrocortisone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00154	CcSEcCtD
Fludrocortisone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00154	CcSEcCtD
Fludrocortisone—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00153	CcSEcCtD
Fludrocortisone—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00152	CcSEcCtD
Fludrocortisone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000121	0.00152	CcSEcCtD
Fludrocortisone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00152	CcSEcCtD
Fludrocortisone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00152	CcSEcCtD
Fludrocortisone—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00152	CcSEcCtD
Fludrocortisone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00152	CcSEcCtD
Fludrocortisone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00149	CcSEcCtD
Fludrocortisone—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00147	CcSEcCtD
Fludrocortisone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00146	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00146	CcSEcCtD
Fludrocortisone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00146	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00146	CcSEcCtD
Fludrocortisone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00146	CcSEcCtD
Fludrocortisone—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00146	CcSEcCtD
Fludrocortisone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00145	CcSEcCtD
Fludrocortisone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00145	CcSEcCtD
Fludrocortisone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00144	CcSEcCtD
Fludrocortisone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000114	0.00144	CcSEcCtD
Fludrocortisone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000114	0.00143	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000114	0.00143	CcSEcCtD
Fludrocortisone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00142	CcSEcCtD
Fludrocortisone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00142	CcSEcCtD
Fludrocortisone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000112	0.00141	CcSEcCtD
Fludrocortisone—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.0014	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00138	CcSEcCtD
Fludrocortisone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00138	CcSEcCtD
Fludrocortisone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00137	CcSEcCtD
Fludrocortisone—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00136	CcSEcCtD
Fludrocortisone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00135	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00135	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00134	CcSEcCtD
Fludrocortisone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000106	0.00133	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00133	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000106	0.00133	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.00133	CcSEcCtD
Fludrocortisone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.00132	CcSEcCtD
Fludrocortisone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000105	0.00132	CcSEcCtD
Fludrocortisone—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00131	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000103	0.0013	CcSEcCtD
Fludrocortisone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000103	0.00129	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00129	CcSEcCtD
Fludrocortisone—Injury—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00127	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	9.98e-05	0.00126	CcSEcCtD
Fludrocortisone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	9.9e-05	0.00125	CcSEcCtD
Fludrocortisone—Purpura—Prednisone—chronic obstructive pulmonary disease	9.63e-05	0.00121	CcSEcCtD
Fludrocortisone—Headache—Aminophylline—chronic obstructive pulmonary disease	9.55e-05	0.0012	CcSEcCtD
Fludrocortisone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.21e-05	0.00116	CcSEcCtD
Fludrocortisone—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.21e-05	0.00116	CcSEcCtD
Fludrocortisone—Affect lability—Prednisone—chronic obstructive pulmonary disease	9.14e-05	0.00115	CcSEcCtD
Fludrocortisone—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.02e-05	0.00114	CcSEcCtD
Fludrocortisone—Headache—Tiotropium—chronic obstructive pulmonary disease	9e-05	0.00113	CcSEcCtD
Fludrocortisone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	8.88e-05	0.00112	CcSEcCtD
Fludrocortisone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	8.84e-05	0.00111	CcSEcCtD
Fludrocortisone—Mood swings—Prednisone—chronic obstructive pulmonary disease	8.8e-05	0.00111	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	8.7e-05	0.0238	CbGpPWpGaD
Fludrocortisone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	8.7e-05	0.0011	CcSEcCtD
Fludrocortisone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	8.54e-05	0.00108	CcSEcCtD
Fludrocortisone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	8.54e-05	0.00108	CcSEcCtD
Fludrocortisone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.37e-05	0.00105	CcSEcCtD
Fludrocortisone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.32e-05	0.00105	CcSEcCtD
Fludrocortisone—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.32e-05	0.00105	CcSEcCtD
Fludrocortisone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	8.19e-05	0.00103	CcSEcCtD
Fludrocortisone—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.15e-05	0.00103	CcSEcCtD
Fludrocortisone—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	8.08e-05	0.00102	CcSEcCtD
Fludrocortisone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.07e-05	0.00102	CcSEcCtD
Fludrocortisone—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	7.87e-05	0.000991	CcSEcCtD
Fludrocortisone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	7.86e-05	0.000989	CcSEcCtD
Fludrocortisone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000984	CcSEcCtD
Fludrocortisone—Erythema—Prednisolone—chronic obstructive pulmonary disease	7.7e-05	0.000969	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	7.31e-05	0.02	CbGpPWpGaD
Fludrocortisone—Headache—Arformoterol—chronic obstructive pulmonary disease	7.26e-05	0.000915	CcSEcCtD
Fludrocortisone—Headache—Formoterol—chronic obstructive pulmonary disease	7.26e-05	0.000915	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000911	CcSEcCtD
Fludrocortisone—Headache—Montelukast—chronic obstructive pulmonary disease	7.12e-05	0.000896	CcSEcCtD
Fludrocortisone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	6.91e-05	0.00087	CcSEcCtD
Fludrocortisone—Headache—Salbutamol—chronic obstructive pulmonary disease	6.86e-05	0.000864	CcSEcCtD
Fludrocortisone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	6.67e-05	0.000839	CcSEcCtD
Fludrocortisone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.64e-05	0.000836	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—chronic obstructive pulmonary disease	6.55e-05	0.0179	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	6.49e-05	0.0177	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	6.46e-05	0.000813	CcSEcCtD
Fludrocortisone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.000809	CcSEcCtD
Fludrocortisone—Oedema—Prednisolone—chronic obstructive pulmonary disease	6.28e-05	0.000791	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.28e-05	0.000791	CcSEcCtD
Fludrocortisone—Progesterone—CYP1A1—chronic obstructive pulmonary disease	6.27e-05	0.0768	CrCbGaD
Fludrocortisone—Prednisone—ALB—chronic obstructive pulmonary disease	6.08e-05	0.0745	CrCbGaD
Fludrocortisone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.07e-05	0.000764	CcSEcCtD
Fludrocortisone—Progesterone—CYP1A2—chronic obstructive pulmonary disease	6.04e-05	0.0741	CrCbGaD
Fludrocortisone—Testosterone—CYP1A1—chronic obstructive pulmonary disease	5.92e-05	0.0726	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	5.9e-05	0.0161	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	5.73e-05	0.0703	CrCbGaD
Fludrocortisone—Methyltestosterone—ALB—chronic obstructive pulmonary disease	5.69e-05	0.0697	CrCbGaD
Fludrocortisone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.68e-05	0.000715	CcSEcCtD
Fludrocortisone—Erythema—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000704	CcSEcCtD
Fludrocortisone—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.02e-05	0.000632	CcSEcCtD
Fludrocortisone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	4.99e-05	0.000628	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	4.92e-05	0.0134	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	4.91e-05	0.0134	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	4.87e-05	0.0133	CbGpPWpGaD
Fludrocortisone—Convulsion—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.00061	CcSEcCtD
Fludrocortisone—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000608	CcSEcCtD
Fludrocortisone—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.000599	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	4.65e-05	0.0127	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.63e-05	0.000583	CcSEcCtD
Fludrocortisone—Oedema—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.000575	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.000575	CcSEcCtD
Fludrocortisone—Infection—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.000571	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	4.51e-05	0.0123	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.000555	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	4.24e-05	0.0116	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	4.2e-05	0.0115	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	4.19e-05	0.0114	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.16e-05	0.000523	CcSEcCtD
Fludrocortisone—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.13e-05	0.00052	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	4.03e-05	0.011	CbGpPWpGaD
Fludrocortisone—Headache—Prednisolone—chronic obstructive pulmonary disease	3.93e-05	0.000495	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	3.92e-05	0.0107	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	3.75e-05	0.0102	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	3.73e-05	0.0102	CbGpPWpGaD
Fludrocortisone—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.63e-05	0.000456	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	3.56e-05	0.00973	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	3.53e-05	0.00963	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	3.5e-05	0.00955	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	3.38e-05	0.00924	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.36e-05	0.000423	CcSEcCtD
Fludrocortisone—Testosterone—ALB—chronic obstructive pulmonary disease	3.3e-05	0.0404	CrCbGaD
Fludrocortisone—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	3.28e-05	0.00896	CbGpPWpGaD
Fludrocortisone—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.27e-05	0.000412	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	3.25e-05	0.00887	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	3.18e-05	0.00869	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	3.17e-05	0.00866	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	3.14e-05	0.00857	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	2.91e-05	0.00794	CbGpPWpGaD
Fludrocortisone—Headache—Prednisone—chronic obstructive pulmonary disease	2.86e-05	0.00036	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	2.71e-05	0.00741	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	2.57e-05	0.00703	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	2.54e-05	0.00693	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	2.45e-05	0.0067	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	2.41e-05	0.00657	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	2.29e-05	0.00626	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	2.21e-05	0.00603	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	2.1e-05	0.00574	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	2.07e-05	0.00566	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	2.02e-05	0.00551	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	1.95e-05	0.00533	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	1.82e-05	0.00497	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.00493	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	1.75e-05	0.00477	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	1.74e-05	0.00475	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	1.71e-05	0.00467	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	1.71e-05	0.00466	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.68e-05	0.00459	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	1.65e-05	0.0045	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	1.59e-05	0.00434	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	1.53e-05	0.00417	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	1.41e-05	0.00384	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.33e-05	0.00362	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	1.32e-05	0.00361	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1.29e-05	0.00353	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	1.29e-05	0.00351	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	1.24e-05	0.00338	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.0033	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.19e-05	0.00326	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	1.16e-05	0.00316	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	1.13e-05	0.0031	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.11e-05	0.00302	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.1e-05	0.003	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	1.04e-05	0.00284	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.01e-05	0.00275	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	1e-05	0.00274	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	9.89e-06	0.0027	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	9.8e-06	0.00268	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	9.72e-06	0.00265	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.42e-06	0.00257	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	8.94e-06	0.00244	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	8.4e-06	0.00229	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	8.38e-06	0.00229	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.3e-06	0.00227	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	8.23e-06	0.00225	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	7.94e-06	0.00217	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	7.84e-06	0.00214	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	7.81e-06	0.00213	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.78e-06	0.00185	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	6.36e-06	0.00174	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	6.02e-06	0.00164	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.92e-06	0.00162	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.82e-06	0.00104	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.9e-06	0.000791	CbGpPWpGaD
